Free Trial
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

$16.38
-2.90 (-15.04%)
(As of 07/17/2024 ET)
Today's Range
$16.30
$18.83
50-Day Range
$6.90
$19.51
52-Week Range
$3.78
$20.44
Volume
280,416 shs
Average Volume
223,226 shs
Market Capitalization
$904.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Pulse Biosciences MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
15.29% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.60
Upright™ Environmental Score
News Sentiment
0.68mentions of Pulse Biosciences in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$85,600 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.16 out of 5 stars

Medical Sector

778th out of 914 stocks

Surgical & Medical Instruments Industry

88th out of 99 stocks

PLSE stock logo

About Pulse Biosciences Stock (NASDAQ:PLSE)

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

PLSE Stock Price History

PLSE Stock News Headlines

Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $18.58
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $16.13
I’m giving you the name of this investment for free
What people don’t know is that Roivant is capitalizing on a wealth secret that goes back over a century. There are a few other public companies who are as well. Only you don’t know it… because it’s not something they openly talk about. That’s why I made this presentation. I want to expose you to a wealth-building secret that you deserve to benefit from.
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $15.51
I’m giving you the name of this investment for free
What people don’t know is that Roivant is capitalizing on a wealth secret that goes back over a century. There are a few other public companies who are as well. Only you don’t know it… because it’s not something they openly talk about. That’s why I made this presentation. I want to expose you to a wealth-building secret that you deserve to benefit from.
See More Headlines
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Today
7/17/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

Net Income
$-42,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$700,000.00
Book Value
$0.81 per share

Miscellaneous

Free Float
15,739,000
Market Cap
$939.84 million
Optionable
Optionable
Beta
1.75
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

PLSE Stock Analysis - Frequently Asked Questions

How have PLSE shares performed this year?

Pulse Biosciences' stock was trading at $12.24 at the beginning of 2024. Since then, PLSE shares have increased by 33.8% and is now trading at $16.38.
View the best growth stocks for 2024 here
.

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences, Inc. (NASDAQ:PLSE) released its earnings results on Tuesday, May, 7th. The company reported ($0.17) earnings per share for the quarter.

What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO?

2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

When did Pulse Biosciences IPO?

Pulse Biosciences (PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

How do I buy shares of Pulse Biosciences?

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA) and Portola Pharmaceuticals (PTLA).

This page (NASDAQ:PLSE) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners